Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 18NIH 2OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 10Stomach Neoplasms 8Prostatic Neoplasms 6Ovarian Neoplasms 5Neoplasms 4Lung Neoplasms 4Colorectal Neoplasms 4Carcinoma, Ovarian Epithelial 4Endometrial Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Lymphoma, Follicular 2Fallopian Tube Neoplasms 2COVID-19 2Breast Cancer Lymphedema 2Anxiety Disorders 2Adenoma 2Uveitis 1Uterine Cervical Dysplasia 1Stress, Psychological 1Stomatitis 1Skin Neoplasms 1Scleritis 1Renal Insufficiency, Chronic 1Radiation Injuries 1Pulmonary Disease, Chronic Obstructive 1Progression-Free Survival 1Ovarian, Fallopian, and Primary Peritoneal Cancer 1Operable Breast Cancer 1

Interventions

Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation Dose Hypofractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × OTHER_GOV × Breast Carcinoma In Situ × Clear all
NCT05318274 2026-03-23

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Coordinación de Investigación en Salud, Mexico

Phase NA Active not recruiting
72 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡